Alfred P. Wolf mainly investigates Internal medicine, Endocrinology, Positron emission tomography, Central nervous system and Nuclear medicine. His research integrates issues of Anesthesia, Hypofrontality and Detoxification in his study of Internal medicine. As part of the same scientific family, Alfred P. Wolf usually focuses on Endocrinology, concentrating on Receptor and intersecting with Benperidol.
His work carried out in the field of Positron emission tomography brings together such families of science as Biophysics, Schizophrenia, Chemotherapy and Pathology. His Nuclear medicine research incorporates themes from Alzheimer's disease, Tomography and Glucose utilization. His Dopamine research includes themes of Pharmacology and Neurotransmitter.
His primary areas of study are Radiochemistry, Internal medicine, Positron emission tomography, Endocrinology and Nuclear medicine. Alfred P. Wolf combines subjects such as Yield, Cyclotron, Nuclear chemistry, Irradiation and Carbon with his study of Radiochemistry. In Internal medicine, Alfred P. Wolf works on issues like Schizophrenia, which are connected to Psychosis.
His Positron emission tomography research is multidisciplinary, incorporating perspectives in Brain positron emission tomography, Alzheimer's disease and Pathology. His Endocrinology study typically links adjacent topics like Receptor. Alfred P. Wolf regularly ties together related areas like Pharmacology in his Striatum studies.
Alfred P. Wolf mainly focuses on Internal medicine, Endocrinology, Dopamine, Pharmacology and Positron emission tomography. His work deals with themes such as Schizophrenia and Psychosis, which intersect with Internal medicine. Alfred P. Wolf works mostly in the field of Endocrinology, limiting it down to topics relating to Receptor and, in certain cases, Stereochemistry, as a part of the same area of interest.
Alfred P. Wolf has researched Dopamine in several fields, including Neurotransmitter, Binding site and Human brain. His research in Pharmacology intersects with topics in Monoamine oxidase, Enzyme and Cocaine binding. His Positron emission tomography research incorporates elements of Brain positron emission tomography and Nuclear magnetic resonance.
Internal medicine, Endocrinology, Dopamine, Pharmacology and Central nervous system are his primary areas of study. Internal medicine is closely attributed to Psychosis in his study. The concepts of his Endocrinology study are interwoven with issues in Receptor, Lorazepam and Detoxification.
His Dopamine research includes elements of Baboon and Neurotransmitter. The Pharmacology study combines topics in areas such as Analysis of variance, Smoking cessation, Monoamine oxidase, Dopamine receptor and Addiction. His Central nervous system research is multidisciplinary, relying on both Haloperidol, Positron emission tomography, Metabolism and Thalamus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man.
M Reivich;D Kuhl;A Wolf;J Greenberg.
Circulation Research (1979)
Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects
Jean Logan;Joanna S. Fowler;Nora D. Volkow;Alfred P. Wolf.
Journal of Cerebral Blood Flow and Metabolism (1990)
Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers
Nora D. Volkow;Joanna S. Fowler;Gene‐Jack ‐J Wang;Robert Hitzemann;Robert Hitzemann.
Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography
G. Di Chiro;R. L. DeLaPaz;R. A. Brooks;L. Sokoloff.
Inhibition of monoamine oxidase B in the brains of smokers
J. S. Fowler;N. D. Volkow;N. D. Volkow;G.-J. Wang;N. Pappas.
Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose.
Brian M. Gallagher;Joanna S. Fowler;Neal I. Gutterson;Robert R. MacGregor.
The Journal of Nuclear Medicine (1978)
Is Methylphenidate Like Cocaine?: Studies on Their Pharmacokinetics and Distribution in the Human Brain
Nora D. Volkow;Nora D. Volkow;Yu Shin Ding;Joanna S. Fowler;Gene Jack Wang.
Archives of General Psychiatry (1995)
A Fluorinated Glucose Analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic Tracer for Rapid Tumor Detection
P Som;H L Atkins;D Bandoypadhyay;J S Fowler.
The Journal of Nuclear Medicine (1980)
Changes in brain glucose metabolism in cocaine dependence and withdrawal.
Nora D. Volkow;Joanna S. Fowler;Alfred P. Wolf;Robert Hitzemann.
American Journal of Psychiatry (1991)
Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose.
M. Reivich;A. Alavi;A. Wolf;J. Fowler.
Journal of Cerebral Blood Flow and Metabolism (1985)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: